"Dune"-inspired Arrakis Therapeutics has tested its spice—an RNA-targeting small molecule—in a mouse model of myotonic ...

Pharma giant GSK is buying into Rgenta Therapeutics’ mission to develop a pipeline of oral RNA-targeting small molecules. | ...

Adding to the ever-growing list of newly discovered bacterial immune systems, we have characterized the mechanisms of an ...

ArrakisTx was formed to create RNA-intercepting drugs to fight cancer. Despite some promising data, CEO @michael_gilman says it will shift targets.

According to the latest study from BCC Research, the demand for RNA Sequencing: Technologies and Global Markets is expected to grow from $4.3 billion in 2024 to $10.3 billion by the end of 2029, at a ...

By deducing the possible ancient forms of a bacterial enzyme, OIST scientists have resurrected one of its ancestral versions, ...

In all living organisms, DNA contains the code that defines cellular structures and functions. An enzyme called RNA ...

LMU researchers have investigated how cationic polymers organize on a molecular level when transporting RNA drugs.

Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules ...

The United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA ...

Researchers investigate the influence of Mettl1 on energy metabolism and the maturation of heart cells after birth.

Researchers have developed TRISCO, a cutting-edge microscopy method that enables 3D RNA analysis in whole, intact mouse ...